|
EORTC QLQ-C30
|
At the hospital
|
At home (1 week later)
|
At home (2 weeks later)
|
Time point (main effect) F/p values
|
|---|
|
Estimated mean (95% CI)
| |
|---|
|
Fatigue
|
34.2 1w, 2w(29.2-39.3)
|
43.3
Ho, 2w
(38.2-48.3)
|
39.8
Ho, 1w
(34.4-45.1)
|
F = 21.40; p < 0.001
|
|
Nausea/Vomiting
|
6.1 1w(3.3-8.9)
|
12.7
Ho, 2w
(9.8-15.5)
|
8.3 1w(5.2-11.4)
|
F = 19.89; p < 0.001
|
|
Pain
|
18.7(13.5-24.0)
|
21.7(16.4-27.0)
|
21.6(16.0-27.1)
|
F = 2.51; p = 0.083
|
|
Dyspnoea
|
22.8 1w(16.1-29.5)
|
26.3 Ho, 2w(19.6-33.1)
|
22.9 1w(16.0-29.8)
|
F = 3.92; p = 0.021
|
|
Sleeping Disturbances
|
26.0 1w(20.1-32.0)
|
34.4
Ho, 2w
(28.4-40.5)
|
29.6 1w(23.3-36.0)
|
F = 12.37; p < 0.001
|
|
Appetite Loss
|
12.8 1w(7.5-18.1)
|
21.7
Ho, 2w
(16.4-27.1)
|
15.6 1w(9.9-21.3)
|
F = 14.94; p < 0.001
|
|
Constipation
|
13.3 1w, 2w(8.1-18.5)
|
23.1
Ho
(17.8-28.4)
|
19.4
Ho
(13.7-25.2)
|
F = 13.70; p < 0.001
|
|
Diarrhoea
|
7.1(4.1-10.2)
|
7.3(4.2-10.3)
|
6.0(2.6-9.3)
|
F = 0.46; p = 0.634
|
|
Financial Impact
|
16.6(10.5-22.7)
|
18.4(12.3-24.5)
|
18.9 (12.6-25.1)
|
F = 2.94; p = 0.054
|
- superscript numbers indicate significance (p < 0.05) of post-hoc group comparisons (LSD-test).
- score differences to the hospital-based assessment exceeding 5 points are given in bold letters.
